Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5193826
Max Phase: Preclinical
Molecular Formula: C34H53NO9
Molecular Weight: 619.80
Associated Items:
ID: ALA5193826
Max Phase: Preclinical
Molecular Formula: C34H53NO9
Molecular Weight: 619.80
Associated Items:
Canonical SMILES: CC(/C=C/[C@H]1O[C@H](CC(=O)OC(C)(C)C)C[C@@]2(CO2)[C@@H]1O)=C\C[C@@H]1O[C@H](C)[C@H](NC(=O)/C=C\[C@H](C)OC(=O)C(C)C)C[C@@H]1C
Standard InChI: InChI=1S/C34H53NO9/c1-20(2)32(39)41-23(5)12-15-29(36)35-26-16-22(4)27(42-24(26)6)13-10-21(3)11-14-28-31(38)34(19-40-34)18-25(43-28)17-30(37)44-33(7,8)9/h10-12,14-15,20,22-28,31,38H,13,16-19H2,1-9H3,(H,35,36)/b14-11+,15-12-,21-10+/t22-,23-,24+,25+,26+,27-,28+,31+,34+/m0/s1
Standard InChI Key: NFPIGBQZCXDROF-ZIVTWHCVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 619.80 | Molecular Weight (Monoisotopic): 619.3720 | AlogP: 4.34 | #Rotatable Bonds: 11 |
Polar Surface Area: 132.92 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.92 | CX Basic pKa: | CX LogP: 4.01 | CX LogD: 4.01 |
Aromatic Rings: 0 | Heavy Atoms: 44 | QED Weighted: 0.15 | Np Likeness Score: 2.03 |
1. Ghosh AK, Mishevich JL, Jurica MS.. (2021) Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors., 84 (5.0): [PMID:33974423] [10.1021/acs.jnatprod.1c00100] |
Source(1):